The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment of essential thrombocytopenia patients intolerant/ resistant to hydroxyurea: A physician survey.
 
Bijan Nejadnik
Employment - Galena Biopharma; Jazz Pharmaceuticals
Leadership - Galena Biopharma
Stock and Other Ownership Interests - Galena Biopharma; Jazz Pharmaceuticals
Honoraria - Galena Biopharma
Consulting or Advisory Role - Galena Biopharma
Research Funding - Galena Biopharma
Travel, Accommodations, Expenses - Galena Biopharma
Other Relationship - Galena Biopharma
 
John Mascarenhas
Consulting or Advisory Role - Galena Biopharma
 
Karen M Rappaport
Employment - Jazz Pharmaceuticals (I); Quark (I)
Consulting or Advisory Role - Galena Biopharma; Immune Design; Pharmacyclics (I); Portola Pharmaceuticals
 
Biao Lu
Stock and Other Ownership Interests - Luxena Pharmaceuticals
Consulting or Advisory Role - Galena Biopharma
Patents, Royalties, Other Intellectual Property - Luxena Pharmaceuticals
 
Bruno M Gagnon
Employment - Xenon Clinical Consulting; Xenon Clinical Consulting (I)
Stock and Other Ownership Interests - Comprehend Systems
Honoraria - Galena Biopharma; MyoKardia; Raptor Pharmaceuticals; True North Therapeutics
Consulting or Advisory Role - Galena Biopharma; MyoKardia; Raptor Pharmaceuticals
Other Relationship - Protocol First
 
Srdan Verstovsek
Research Funding - AstraZeneca; Blueprint Medicines; Bristol-Myers Squibb; Celgene; CTI Biopharma Corp; Galena Biopharma; Genentech; Geron; Gilead Sciences; Incyte; Lilly; NS Pharma; Pfizer; Promedior; Roche; Seagen